Kimberlee S Caple's most recent trade in Castle Biosciences Inc was a trade of 13,667 Restricted Stock Units done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,667 | 13,667 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 8,673 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 8,673 | 22,454 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2024 | 440 | 13,781 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2024 | 440 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 8,636 | 13,341 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 8,636 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 8,673 | 8,673 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 440 | 440 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 440 | 4,705 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 3,825 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 3,825 | 4,265 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kimberlee S. Caple | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 8,636 | 8,636 | - | - | Restricted Stock Units |